Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.56 |
| ▸ | PTPN11 | Q06124 | 7/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5090283 | 0.98 | PLA2G2A (0.59) | PLA2G2APTPN11S1PR3TP53TSHR | |
| SCHEMBL11049569 | 0.98 | PLA2G2A (0.59) | PLA2G2APTPN11S1PR3TP53TSHR | |
| SCHEMBL5095051 | 0.98 | PLA2G2A (0.59) | PLA2G2APTPN11S1PR3TP53TSHR | |
| SCHEMBL23748722 | 0.85 | TSHR (0.53) | PLA2G2ATP53TSHR | |
| SCHEMBL23352171 | 0.85 | PLA2G2A (0.56) | PLA2G2APTPN11S1PR3TP53TSHR | |
| SCHEMBL9413365 | 0.84 | ALDH1A1 (0.41) | PLA2G2APTPN11 | |
| SCHEMBL23748671 | 0.84 | PTPN11 (0.48) | PLA2G2APTPN11S1PR3 | |
| SCHEMBL9304719 | 0.84 | PLA2G2A (0.59) | PLA2G2APTPN11S1PR3TP53TSHR | |
| SCHEMBL9700149 | 0.84 | PLA2G2A (0.59) | PLA2G2APTPN11S1PR3TP53TSHR | |
| SCHEMBL7089935 | 0.81 | PLA2G2A (0.56) | PLA2G2APTPN11TP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473249-B2 | Aromatic compounds and pharmaceutical uses thereof | BASF AS (NO) | 2025-11-18 | — | — | US | disclosed |
| US-20210380521-A1 | AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | BASF AS (NO) | 2021-12-09 | — | — | US | disclosed |
| US-20210380521-A1 | AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | BASF AS (NO) | 2021-12-09 | — | — | US | disclosed |
| EP-3864001-A1 | ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | BASF AS (NO) | 2021-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12473249-B2 | Aromatic compounds and pharmaceutical uses thereof | GLS2, FFAR3, SLC10A1 | PLA2G2A 334/4885PTPN11 1287/4885S1PR3 58/4885 |
| US-20210380521-A1 | AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF | GLS2, FFAR3, SLC10A1 | PLA2G2A 334/4885PTPN11 1287/4885S1PR3 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.